These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9264375)

  • 1. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.
    Fielder W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Leukemia; 1997 Aug; 11(8):1234-7. PubMed ID: 9264375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
    Kaipainen A; Korhonen J; Pajusola K; Aprelikova O; Persico MG; Terman BI; Alitalo K
    J Exp Med; 1993 Dec; 178(6):2077-88. PubMed ID: 8245783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
    Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
    Jeha S; Smith FO; Estey E; Shen Y; Liu D; Manshouri T; Albitar M
    Leuk Res; 2002 Apr; 26(4):399-402. PubMed ID: 11839384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
    de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
    Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
    Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
    Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
    Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
    Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of murine Flt4 ligand/VEGF-C.
    Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
    Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
    Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
    Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.
    Lymboussaki A; Olofsson B; Eriksson U; Alitalo K
    Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
    Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.